Transition From Pde-5 Inhibitors To Riociguat In Pulmonary Hypertension

被引:0
|
作者
Weir, N. [1 ]
Brown, A. W. [2 ]
DelaSantina, J. [2 ]
King, C. [2 ]
Lewis, D. [1 ]
Franco-Palacios, D. [2 ]
Nathan, S. D. [1 ]
Shlobin, O. A. [2 ]
机构
[1] Inova Fairfax Hosp, Falls Church, VA USA
[2] Inova Fairfax Hosp, Kensington, MD USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2282
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors
    Lobo, JR
    Nehra, A
    UROLOGIC CLINICS OF NORTH AMERICA, 2005, 32 (04) : 447 - +
  • [42] Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
    E.Deconinck
    S.Andriessens
    J.L.Bothy
    P.Courselle
    J.O.De Beer
    JournalofPharmaceuticalAnalysis, 2014, 4 (04) : 250 - 257
  • [43] Effects of PDE-5 inhibitor on pulmonary macro- and microcirculation
    Milekhin, V.
    Pizanis, N.
    Maykan, R.
    Butrous, G.
    Jakob, H.
    Kamler, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S62 - S62
  • [44] MULTIFUNCTIONALILTY OF SILDENAFIL, AN PDE-5 INHIBITOR - PULMONARY VASODILATATION AND BEYOND
    Saji, Tsutomu
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 45 - 45
  • [45] Effects of PDE-5 inhibitor on pulmonary macro- and microcirculation
    Milekhin, V.
    Pizanis, N.
    Kaiser, K.
    Maykan, R.
    Butrous, G.
    Jakob, H.
    Kamler, M.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 81 - 81
  • [46] Sudden Hearing Loss From PDE-5 Inhibitors: A Possible Cellular Stress Etiology
    Maddox, Patrick T.
    Saunders, James
    Chandrasekhar, Sujana S.
    LARYNGOSCOPE, 2009, 119 (08): : 1586 - 1589
  • [47] Increased NO-synthase activity and beneficial effect of PDE-5 inhibition by sildenafil in pulmonary hypertension caused by pulmonary embolism
    Mizera, Roman
    Hodyc, Daniel
    Herget, Jan
    FASEB JOURNAL, 2014, 28 (01):
  • [48] Riociguat for Pulmonary Hypertension
    Egom, Emmanuel E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23): : 2266 - 2267
  • [49] Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
    Gheorghiu, Oana Ramona Catalina
    Ciobanu, Anne Marie
    Gutu, Claudia Maria
    Chitescu, Carmen Lidia
    Costea, Giorgiana Valentina
    Anghel, Daniela Madalina
    Vlasceanu, Ana Maria
    Baconi, Daniela Luiza
    MOLECULES, 2023, 28 (10):
  • [50] Riociguat for pulmonary hypertension
    Cannon, John E.
    Pepke-Zaba, Joanna
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 259 - 270